NCT00106353
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +2 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site Chicago, Illinois, United States
- Pfizer Investigational Site Indianapolis, Indiana, United States